Improving patient responses to immunotherapy

Published Erin Turner on Mon, 02/27/2023 - 10:39

Monday Lunch Livestream

with Associate Professor Jane Oliaro

12 December 2022

Immunotherapies take advantage of our immune system to fight cancer and have revolutionised modern cancer treatment.

Associate Professor Jane Oliaro presents us with research aimed at discovering new therapeutic targets to improve patient responses to immunotherapies.

The results of her lab's work highlight a role for tumour necrosis factor (TNF)-mediated bystander killing as a potent immune cell effector mechanism. The data generated also identifies new genes and pathways that may predict response to checkpoint blockade, or be therapeutically targeted to improve the number of patients that benefit from immunotherapy. 

 

Course Details

Banner Blue Triangles
Course type
Webinars
Duration
60 mins
Price
$0.00
Curriculum Area
Leadership and Non-Technical Skills
Speciality
Senior researcher / scientist
Early to mid career researcher
Clinician
Nurse
Monday Lunch Live
Research
Immunotherapy

This course is brought to you by

Alliance members